You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

TRIAMCINOLONE DIACETATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for triamcinolone diacetate and what is the scope of patent protection?

Triamcinolone diacetate is the generic ingredient in three branded drugs marketed by Fosun Pharma, Epic Pharma Llc, Watson Labs, Astellas, and Delcor Asset Corp, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for triamcinolone diacetate.

Summary for TRIAMCINOLONE DIACETATE

US Patents and Regulatory Information for TRIAMCINOLONE DIACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Delcor Asset Corp KENACORT triamcinolone diacetate SYRUP;ORAL 012515-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fosun Pharma ARISTOCORT triamcinolone diacetate INJECTABLE;INJECTION 012802-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs TRIAMCINOLONE DIACETATE triamcinolone diacetate INJECTABLE;INJECTION 085529-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astellas ARISTOCORT triamcinolone diacetate SYRUP;ORAL 011960-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Epic Pharma Llc TRIAMCINOLONE DIACETATE triamcinolone diacetate INJECTABLE;INJECTION 085122-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fosun Pharma ARISTOCORT triamcinolone diacetate INJECTABLE;INJECTION 011685-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs TRIAMCINOLONE DIACETATE triamcinolone diacetate INJECTABLE;INJECTION 084072-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.